JUN LIU: Open Payments
NPI 1184019903 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,499 in 99 payments from 16 companies in 2025. Trend: 2023 $1,288 · 2024 $1,678 · 2025 $1,499
Food & beverage: $1,499
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $283 |
| Otsuka America Pharmaceutical, Inc. | 18 | $220 |
| Corium, LLC | 10 | $216 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $215 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $102 |
| Axsome Therapeutics, Inc. | 5 | $77 |
| Teva Pharmaceuticals USA, Inc. | 4 | $77 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Janssen Pharmaceuticals, Inc | 4 | $62 |
| Alkermes, Inc. | 2 | $42 |
Products named: VRAYLAR, REXULTI, Azstarys, CAPLYTA, TRINTELLIX, Auvelity, FANAPT, SPRAVATO.
Industry payments across AL — which companies pay providers there.
